33 Grants (Page 1 of 2)
2018
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
Farag, Sherif S and Pelus, Louis M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA182947-05), $319,738USD, 05/01/2014 -- 04/30/2019
2017
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
Farag, Sherif S and Pelus, Louis M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA182947-04), $321,933USD, 05/01/2014 -- 04/30/2019
2016
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 4R01HL112669-05), $720,299USD, 03/01/2012 -- 02/28/2017
 
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
Farag, Sherif S and Pelus, Louis M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA182947-03), $321,933USD, 05/01/2014 -- 04/30/2019
2015
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL112669-04), $720,286USD, 03/01/2012 -- 02/28/2017
 
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
Farag, Sherif S and Pelus, Louis M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA182947-02), $325,817USD, 05/01/2014 -- 04/30/2019
2014
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL112669-03), $727,047USD, 03/01/2012 -- 02/28/2017
 
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
Farag, Sherif S and Pelus, Louis M
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA182947-01), $349,482USD, 05/01/2014 -- 04/30/2019
2013
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL112669-02), $716,107USD, 03/01/2012 -- 02/28/2017
2012
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL112669-01), $760,603USD, 03/01/2012 -- 02/28/2017
2011
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA141404-02), $309,964USD, 02/01/2010 -- 01/31/2013
2010
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA141404-01A1), $319,550USD, 02/01/2010 -- 01/31/2012
 
Pathology
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P01CA101956-05-9002), $337,691USD, 2010
2009
Leukemia Tissue Bank
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA016058-34-9031), $69,365USD, 2009
 
Pathology
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P01CA101956-04-9002), $331,401USD, 2009
2008
Leukemia Tissue Bank
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA016058-33-9031), $66,366USD, 2008
 
Pathology
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P01CA101956-03-9002), $321,393USD, 2008
 
QMS Technology to Deplete T Cell Alloreactivity
Farag, Sherif S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI056318-06), $588,648USD, 05/01/2004 -- 04/30/2010
2007
Leukemia Tissue Bank
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA016058-32-9031), $59,639USD, 2007
 
Pathology
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P01CA101956-02-9002), $319,401USD, 2007
 
QMS Technology to Deplete T Cell Alloreactivity
Farag, Sherif S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI056318-05), $609,680USD, 05/01/2004 -- 04/30/2009
2006
Leukemia Tissue Bank
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5P30CA016058-31-9031), $34,863USD, 2006
 
Pathology
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1P01CA101956-01A2-9002), $208,536USD, 07/01/2005 -- 06/30/2011
 
QMS Technology to Deplete T Cell Alloreactivity
Farag, Sherif S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 7R01AI056318-04), $595,781USD, 05/01/2004 -- 04/30/2009
2005
Leukemia Tissue Bank
Farag, Sherif S
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2P30CA016058-30-9031), $33,847USD, 08/24/2005 -- 11/30/2009